Market Cap (In INR)
45.84 Billion
Revenue (In INR)
12.44 Billion
Net Income (In INR)
1.23 Billion
Avg. Volume
659.78 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 154.5-529.9
- PE
- -
- EPS
- -
- Beta Value
- 0.814
- ISIN
- INE681B01017
- CUSIP
- Y39886125
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Mr. Shivakumar Pattabhiraman ACA, B Com, CWA, Grad.
- Employee Count
- -
- Website
- https://www.delhi.apollohospitals.com
- Ipo Date
- 1997-05-07
- Details
- Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology/diabetes care, ENT, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology. The company operates cosmetic and dental clinics. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India.
More Stocks
-
CBECobre Limited
CBE
-
NKRKFNokian Renkaat Oyj
NKRKF
-
KWE
-
HIKALHikal Limited
HIKAL
-
PBSV
-
GAEL
-
ILU
-
DNZOFDENSO Corporation
DNZOF